U.S. Pharma Industry Evolution
Last week's news about Pfizer's $17 billion deal to acquire Hospira, a…
Hepatitis C Drug Battle: What’s Going On?
Just give me the cheapest oneMakers and buyers of new Hepatitis C…
In Praise of FDA Collaboration: The Cardiac Safety Example
The Food and Drug Administration gets a lot of grief. Some think the FDA…
More US Pharmaceutical Industry Downsizing
The U.S. pharmaceutical industry has taken some pretty severe hits over the…
_9.jpg)
BioPharma Beat: Is Commercial Support of CME A Bad Idea?
Let’s start with a few realities: Let’s start with a few realities:More…
How Pharma Can Meet Consumer Expectations
Consumers expect rewards from pharma. When asked “which of the following services would…
Is Hepatitis C Treatment Cost-Effective?
One catch phrase in health care reform is cost-effectiveness. To paraphrase, this…
My Perspective on the High Cost of Cancer Drugs
Dr. Leonard Salz, a renowned GI cancer specialist at Memorial Sloan Kettering…
5 Steps to Achieving URAC Specialty Pharmacy Accreditation
For many patients with complex, chronic illnesses, specialty pharmacies are the crux…
